Kintara Therapeutics, Inc. Analysis
| Analyst Ratings |
|
Average Target Price
|
150.00
|
|
Average Rating
|
3.00
|
|
# Strong Buys
|
0
|
|
# Buys
|
0
|
|
# Holds
|
1
|
|
# Sells
|
0
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2022-09-30
|
-0.18
|
-3.50
|
-3.32
|
-1844.44%
|
|
2022-06-30
|
-1.50
|
-5.50
|
-4.00
|
-266.67%
|
|
2022-03-31
|
-7.50
|
-5.50
|
2.00
|
26.67%
|
|
2021-12-31
|
-8.00
|
-6.00
|
2.00
|
25.00%
|
|
2021-09-30
|
-7.25
|
-12.50
|
-5.25
|
-72.41%
|
|
2021-06-30
|
-8.00
|
-6.50
|
1.50
|
18.75%
|
|
2021-03-31
|
-9.12
|
-11.50
|
-2.38
|
-26.10%
|
|
2020-12-31
|
-7.12
|
-11.00
|
-3.88
|
-54.49%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2022-12-31
|
-3.50
|
|
2022-06-30
|
-29.50
|
|
2021-06-30
|
-30.33
|
|
2020-06-30
|
-0.86
|
|
2019-06-30
|
-3.26
|
|
2018-06-30
|
-5.50
|
|
2017-06-30
|
-0.74
|
|
2016-06-30
|
-0.84
|
|
2015-06-30
|
-1.95
|
|
2014-06-30
|
127.25
|
|
2013-06-30
|
-1049.03
|